E-LIB Suche - Ergebnisse für: Collins, Graham P

1

Nivolumab plus brentuximab vedotin for relapsed/refractory ..:

Zinzani, Pier Luigi ; Salles, Gilles ; Moskowitz, Alison J....
Blood Advances. 8 (2024) 10 - p. 2400-2404 , 2024

Link: https://doi.org/10.1182/..

2

The PI3Kδ inhibitor zandelisib on intermittent dosing in re..:

Zelenetz, Andrew D. ; Jurczak, Wojciech ; Ribrag, Vincent...
HemaSphere. 8 (2024) 8 - p. , 2024

Link: https://doi.org/10.1002/..

3

Brexucabtagene autoleucel for relapsed or refractory mantle..:

O'Reilly, Maeve A. ; Wilson, William ; Burns, David...
HemaSphere. 8 (2024) 6 - p. , 2024

Link: https://doi.org/10.1002/..

4

Older patients with Hodgkin Lymphoma: Walking the tightrope..:

Barrett, Aisling ; Collins, Graham P.
Frontiers in Oncology. 12 (2023) - p. , 2023

Link: https://doi.org/10.3389/..

5

Age, successive waves, immunization, and mortality in elder..:

Rossi, Giuseppe ; Salmanton-García, Jon ; Cattaneo, Chiara...
International Journal of Infectious Diseases. 137 (2023) - p. 98-110 , 2023

Link: https://doi.org/10.1016/..

6

Nivolumab for relapsed/refractory classical Hodgkin lymphom..:

Ansell, Stephen M. ; Bröckelmann, Paul J. ; von Keudell, Gottfried...
Blood Advances. 7 (2023) 20 - p. 6266-6274 , 2023

Link: https://doi.org/10.1182/..

7

PB2296: ROBUST BRUTON'S TYROSINE KINASE (BTK) DEGRADATION W..:

Linton, Kim ; Forconi, Francesco ; Lewis, David...
HemaSphere. 7 (2023) S3 - p. e593178d , 2023

Link: https://doi.org/10.1097/..

8

PB2331: AN ONGOING FIRST-IN-HUMAN PHASE 1 TRIAL OF NX-5948,..:

Linton, Kim ; Doorduijn, Jeanette ; El-Sharkawi, Dima...
HemaSphere. 7 (2023) S3 - p. e29005fd , 2023

Link: https://doi.org/10.1097/..

9

Examining the levels of psychological support available to ..:

Brett, Jo ; Henshall, Catherine ; Dawson, Paul...
BMJ Open. 13 (2023) 2 - p. e060106 , 2023

Link: https://doi.org/10.1136/..

10

Brentuximab vedotin with chemotherapy in adolescents and yo..:

Crosswell, Howland E. ; LaCasce, Ann S. ; Bartlett, Nancy L....
Haematologica. 109 (2023) 3 - p. 982-987 , 2023

Link: https://doi.org/10.3324/..

11

Predicting COVID-19 infection risk in people who are immuno..:

Wijaya, Ratna ; Johnson, Marina ; Campbell, Nicola...
The Lancet. 402 (2023) 10396 - p. 99-102 , 2023

Link: https://doi.org/10.1016/..

12

Survival in multiple myeloma and SARS‐COV‐2 infection throu..:

Musto, Pellegrino ; Salmanton‐García, Jon ; Sgherza, Nicola...
Hematological Oncology. 42 (2023) 1 - p. , 2023

Link: https://doi.org/10.1002/..

13

Phase I Study of Acalabrutinib Plus Danvatirsen (AZD9150) i..:

Roschewski, Mark ; Patel, Manish R. ; Reagan, Patrick M....
Clinical Cancer Research. 29 (2023) 17 - p. 3301-3312 , 2023

Link: https://doi.org/10.1158/..

14

Guideline for the first‐line management of Classical Hodgki..:

Follows, George A. ; Barrington, Sally F. ; Bhuller, Kaljit S....
British Journal of Haematology. 197 (2022) 5 - p. 558-572 , 2022

Link: https://doi.org/10.1111/..

15

A Review of the Prevention of Mother-to-Child Transmission ..:

Barr, Rachael S. ; Drysdale, Simon B. ; Boullier, Mary...
Frontiers in Medicine. 9 (2022) - p. , 2022

Link: https://doi.org/10.3389/..